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Background-—The Physician Consortium for Performance Improvement recently proposed percutaneous coronary intervention
(PCI)-specific process measures. However, information about hospital performance on these measures and the association of PCI
process and outcomes measures are not available.
Methods and Results-—We linked the National Cardiovascular Data Registry (NCDR) CathPCI Registry with Medicare claims data
to assess hospital performance on established PCI process measures (aspirin, thienopyridines, and statins on discharge; door-to-
balloon time; and referral to cardiac rehabilitation), newly proposed PCI process measures (documentation of contrast dose,
glomerular filtration rate, and PCI indication; appropriate indication for elective PCI; and use of embolic protection device), and a
composite of all process measures. We calculated weighted pair-wise correlations between each set of process metrics and
performed weighted correlation analyses to assess the association between composite measure performance with corresponding
30-day risk-standardized mortality and readmission rates. We reported the variance in risk-standardized 30-day outcome rates
explained by process measures. We analyzed 1 268 860 PCIs from 1331 hospitals. For many process measures, median hospital
performance exceeded 90%. We found strong correlations between medication-specific process measures (P<0.01) and weak
correlations between hospital performance on the newly proposed and established process measures. The composite process
measure explained only 1.3% and 2.0% of the observed variation in mortality and readmission rates, respectively.
Conclusions-—Hospital performance on many PCI-specific process measures demonstrated little opportunity for improvement and
explained only a small percentage of hospital variation in 30-day outcomes. Efforts to measure and improve hospital quality for PCI
patients should focus on both process and outcome measures. ( J Am Heart Assoc. 2017;6:e004276. DOI: 10.1161/JAHA.116.
004276.)
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T he past decade has seen a dramatic increase in effortsto measure and report the quality of care delivered to
patients undergoing percutaneous coronary intervention
(PCI).1,2 A number of PCI-related process measures already
exist,3 and there are ongoing efforts both to expand the
number of process measures and implement outcomes
measures to characterize the quality of care for patients
undergoing PCI. Specifically, the Physician Consortium for
Performance Improvement (PCPI) in partnership with
professional societies including American College of Cardiol-
ogy (ACC), American Heart Association, Society for Cardio-
vascular Angiography and Interventions (SCAI) have recently
proposed a set of 11 PCI-related process measures.4 In
addition, the ACC has developed risk-standardized measures
of hospital 30-day mortality and readmission following PCI.5,6
However, we have little information as to how hospitals
currently perform on these measures and whether process
and outcomes measures capture distinct or overlapping
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domains of quality. Every performance measure carries an
opportunity cost in terms of the resources needed to collect
the data and the efforts required to improve performance.7–10
Expanding the portfolio of measures may be warranted if a
new measure provides a more-comprehensive assessment of
hospital quality. However, the extent to which the new
measures achieve this goal has not been demonstrated.
To date, no study has examined hospital performance on
PCI process and outcomes measures. To address this gap in
knowledge, we used data from the ACC’s National Cardio-
vascular Data Registry (NCDR) CathPCI Registry to describe
variation in hospital performance and examine the extent to
which hospital performance on PCI-related measures are
correlated. Specifically, we identified the association of
hospital performance on existing process measures with the
PCPI’s proposed process measures. We then examined
whether hospital quality, as determined by process measures
performance, was correlated with hospital performance on
30-day mortality and readmission.
Methods
Data Sources
With more than 1600 participating hospitals, the NCDR
CathPCI registry, cosponsored by the ACC and the SCAI, is
the largest registry of elective and emergency PCIs in the
United States.11 The registry collects data on patient
demographics, procedural and clinical variables, and in-
hospital outcomes using standardized definitions.12 For this
study, we used registry data reflecting PCIs performed
between January 1, 2010 and December 31, 2011. To
calculate the risk-standardized 30-day mortality and read-
mission rates, we linked registry data with corresponding
Medicare claims data using direct patient identifiers, includ-
ing name, date of birth, and Social Security number.
Information regarding 30-day patient readmissions and
mortality were obtained using Medicare’s Inpatient and
Outpatient Standard Analytical Files and enrollment data-
base. Among patients with more than 1 PCI performed
during a hospitalization, we only included information from
the initial procedure.
Study Design and Population
We performed a cross-sectional analysis of all hospitals in the
registry that reported at least 25 PCI procedures during the
study time period. As a result, we excluded 122 low-volume
hospitals, leaving a total of 1331 hospitals for analysis. To
ensure that our estimates of hospital performance on specific
measures were reliable, we further required that each hospital
have at least 25 procedures for each individual measure.
Accordingly, the number of hospitals included in the calcu-
lation of each measure varies.
Process Measures
We classified PCI process metrics into existing National
Quality Forum (NQF)-endorsed PCI-related process measures
and the newer set of measures proposed by the PCPI. The
NQF-endorsed measures included the following: aspirin at
discharge; thienopyridines at discharge; statins at discharge;
door-to-balloon time under 90 minutes for patients presenting
to the emergency department or under 120 minutes for
patients transferred to a facility, and referral to cardiac
rehabilitation after PCI. Among the 11 new process measures
proposed by the PCPI in 2013, we were able to calculate the
following using data elements currently collected by the
registry: comprehensive documentation of criteria needed to
determine procedural appropriateness; appropriate indica-
tions for elective PCI; use of embolic protection devices in
saphenous vein bypass grafts; documentation of contrast
dose; documentation of a preprocedural assessment of renal
function (glomerular filtration rate [GFR] calculation); optimal
postprocedural medical therapy (defined as aspirin, P2Y12
inhibitors, and statins for all patients upon discharge unless
otherwise contraindicated); and referral to cardiac rehabilita-
tion. There were several measures proposed by the PCPI that
could not be assessed given the available elements in the
registry: documentation of radiation dose and whether or not
a patient’s ability to tolerate and adhere to dual antiplatelet
therapy had been evaluated. Furthermore, we did not consider
physician and hospital PCI volume as potential measures,
given that all hospitals participating in the NCDR registry
routinely receive information about procedural volumes.
For each measure, we identified whether patients were
eligible for that metric and aggregated patient-level results to
calculate the hospital performance in the indicated perfor-
mance measure. Measure-specific inclusion and exclusion
criteria were applied to each case to ensure that the population
used to define performance was appropriate. For door-to-
balloon times, we used different thresholds for ST-segment
elevation myocardial infarction (STEMI) patients who presented
through the emergency department (≤90 minutes) and those
transferred from another acute care facility (≤120 minutes).13
For the documentation of indications for PCI process measure,
we classified a procedure as correctly documented based on
recommendations from the PCPI, which included the follow-
ing: documentation of priority of diagnoses (acute coronary
syndrome vs elective); presence and severity of angina
symptoms; use of antianginal medical therapies within 2 weeks
before the procedure; significance of angiographic stenosis on
coronary angiography for treated lesion; and presence, results,
and timing of noninvasive stress test, fractional flow reserve, or
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intravascular ultrasound. For the measure of the proportion of
elective PCIs considered appropriate, we defined it in a manner
consistent with the PCPI guidelines, which is the sum of the
total number of appropriate and uncertain cases (as opposed to
inappropriate or unmappable) among all non-acute coronary
syndrome PCIs defined in a manner consistent with 2012
appropriate usage criteria.14 Finally, we created composite
measures defined as the total number of process measures
patients received over the total number of eligible performance
measures for patients treated at that hospital. The first
composite measure was restricted to the current NQF-
endorsed PCI process measures, and the second composite
measure included both the current and proposed PCPI
measures.10
Outcome Measures
We calculated hospital-specific risk standardized 30-day
readmission and mortality rates in a manner consistent with
NQF-approved mortality and readmission measures.15,16
Specifically, for mortality, and consistent with the NQF-
approved measures, we used separate models to calculate
hospitals’ risk-standardized 30-day mortality for (1) patients
with STEMI or cardiogenic shock and (2) patients without
STEMI and without cardiogenic shock.16 All outcomes models
use hierarchical logistic regression, which takes into account
clustering of patients within hospitals and use preprocedural
clinical characteristics of patients for risk adjustment.
Statistical Analysis
Crude rates, defined as the number of times a specific
process measure was performed on a patient over the total
number of eligible patients at that hospital, were calculated
for all process measures. To analyze the association between
hospital performance on current and emerging process
metrics, we used the hospital performance estimates for
each process measure to calculate a set of pair-wise
correlations.
In our analysis of the relationship between hospital
performance on current and emerging process measures
with performance on outcome metrics, we used correlation
analyses to determine the association of hospital risk-
standardized 30-day mortality and readmission rates with
corresponding hospital composite score estimates of both the
emerging and existing process measures. We repeated our
analyses, first limiting the composite measure to current
process measures, and again limiting to medication-specific
measures. In each analysis, we calculated both correlation
coefficients and the proportion of the hospital-specific
variation in risk-standardized outcomes explained by perfor-
mance on the composite measures. This variation is the
square of the correlation coefficient and is calculated as a
percentage. We performed secondary analyses to assess the
robustness of our findings, restricting the calculation of
hospital performance on process measures to Medicare
beneficiaries.
Analyses were conducted using SAS software (version 9.3;
SAS Institute Inc., Cary, NC). Given that different numbers of
patients have eligibility for the process measures at each
hospital, analyses were weighted by the total number of
patients from that hospital who were included in the
calculation of the specific process measure. For each
correlation, we tested the null hypothesis that there is no
correlation between measures, adjusting P values for multiple
comparisons using the Sidak correction.17 All analyses were
conducted with an overall family-wise error rate of 0.05. The
Yale University Human Investigations Committee approved
analyses of this limited NCDR data set.
Results
Hospital Performance on Process and Outcomes
Measures
A total of 1 268 860 PCI procedures performed at 1331
hospitals between January 2010 and December 2011 met
criteria for inclusion. Hospital performance on each of the
current process measures, proposed PCPI process measures,
and the composite measure are shown in Figure 1. Among
the current process measures, there was relatively little
variation in hospital performance on the discharge medica-
tions, with median hospital performance above 90%. We
observed a larger gap in performance with regard to timely
primary PCI (median, 78.9%; interquartile range [IQR], 71.2–
85.1%) and referral to cardiac rehabilitation (median, 60.7%;
IQR, 18.4–87.2%). Among the PCPI proposed measures,
hospital performance on measures of documentation was
uniformly high: contrast dose (median, 99.7%; IQR, 98.3–
100%); GFR (median, 97.0%; IQR, 92.8–98.8%); and PCI
indications (median, 99.8%; IQR, 99.2–100%). Larger variation
was observed for use of embolic protection devices (median,
16.5%; IQR, 3.6–33.9%) and the proportion of non-acute
coronary syndrome PCIs considered appropriate or uncertain
(median, 50.0%; IQR, 38.3–61.2%). Variation in hospital 30-
day mortality and readmission rates was modest (Table 1).
Correlation of Existing Process Measures
We found moderate-to-strong correlations (correlation coeffi-
cient, >0.40; P<0.05) between the discharge medication-
related process measures, particularly between aspirin and
thienopyridines at discharge (Table 2). None of the discharge
medication-related process measures for medications were
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significantly correlated with the proportion of patients who
received timely primary PCI. Referral to cardiac rehabilitation
was significantly correlated with other existing process
measures (all correlation coefficients, >0.10; P<0.05). Refer-
ral to cardiac rehabilitation was strongly correlated with the
overall composite measure (correlation coefficient, >0.90;
P<0.01) and was responsible for most of the variation
observed in the composite measure.
Correlation of Existing and Emerging Process
Measures
There were no significant correlations found among the PCPI’s
proposed process measures (all correlation coefficients,
<0.10; all P>0.05; Table 2). However, both the use of embolic
devices in saphenous vein grafts and the proportion of
appropriate elective PCIs were significantly correlated with
the discharge medication process measures. Furthermore, all
of the existing and emerging process measures, with the
exception of documentation of contrast dose, were signifi-
cantly correlated with the overall composite measure con-
sisting of both existing and emerging process metrics.
Correlations of Process Measures With Hospital-
Level Outcome Measures
The overall composite measure was statistically significantly
associated with both risk-standardized readmission rate and
risk-standardized mortality rate (RSMR) for no STEMI/no
shock patients, but it was not correlated with RSMR for
Figure 1. Hospital performance on proposed PCI process measures. Hospital performance on many of the process measures, including
appropriate medications at discharge as well as documentation of contrast dose and GFR documentation, was close to having process metric
performance nearing 100%. Hospital performance on referral to cardiac rehabilitation, use of embolic devices, proportion of PCIs with
documentation of PCI eligibility, and proportion of elective PCIs consider appropriate or uncertain exhibit room for improvement. Central band
represents median, box hinges represent the first and the third quintiles, and whiskers extend to the 5% and 95% percentile. DTB indicates door-
to-balloon; GFR, glomerular filtration rate; NQF, National Quality Forum; PCI, percutaneous coronary intervention; PCPI, Physician Consortium for
Performance Improvement.
Table 1. Hospital Performance on 30-Day Outcomes in 2010–2011*
Variable N 5th Percentile 25th Percentile Median 75th Percentile 95th Percentile
Risk-standardized readmission rate 1076 10.0 11.1 11.8 12.7 14.2
Risk-standardized mortality rate (STEMI or shock) 743 9.5 10.9 12.1 13.4 16.1
Risk-standardized mortality rate (no STEMI and no shock) 1059 1.3 1.6 1.7 2.0 2.6
NSTEMI indicates non-ST segment elevation myocardial infarction; STEMI, ST-elevation myocardial infarction.
*Hospitals were only considered eligible for each measure if they had more than 25 patients.
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STEMI/shock patients (Table 3). Prescriptions of aspirin and
thienopyridines at discharge were significantly correlated with
all 3 outcomes measures. The individual process metrics
explained 0.1% to 1.9% of hospital variation in 30-day risk-
standardized readmission rate, 0% to 2.3% in 30-day RSMR for
STEMI/shock patients, and 0% to 5.8% in 30-day RSMR for
NSTEMI/no shock patients (Table 4). Hospital performance
on the overall composite measure explained relatively little of
the observed variation in 30-day outcomes—ranging from
0.7% for RSMR in STEMI patients to 2.0% in risk-standardized
readmission rate. Hospital performance on outcomes mea-
sures was similar when grouped by quintiles of performance
on the composite process measure (Figure 2). Secondary
analyses demonstrated similar findings when we restricted
the calculation of hospital process measures to include only
Medicare beneficiaries and when we restricted analyses to
the current process measures and the discharge medication-
specific process measures.
Discussion
In this cross-sectional analysis of the NCDR CathPCI registry,
we found that the majority of hospitals performed well on
existing PCI-related process measures. The additional PCI
process measures proposed by PCPI were not strongly
correlated with the existing process measures, but even
among these, there was little variation among hospitals and
thus limited opportunity for improvement. In addition, hospi-
tals’ performance on existing and proposed process measures
were only weakly correlated with hospitals’ 30-day risk-
standardized mortality and readmission rates. Although the
associations were often statistically significant, hospital
performance on PCI-specific process metrics explained only
between 0.0% and 5.8% of observed variation in risk
standardized mortality rates and between 0.0% and 2.0% of
risk-standardized readmission rates. These findings suggest
that process and outcome measures capture complementary,
and not overlapping, domains of quality.
With the exception of the medication-specific process
measures, there is relatively little correlation between existing
and proposed PCI process measures. This finding is consis-
tent with previous studies, suggesting that distinct strategies
are needed to improve performance across different assess-
ments of hospital quality.10,18–20 However, our findings raise
questions as to whether there is enough of a gap in current
performance to justify further investment in the proposed
PCPI metrics. We found that hospital performance on many of
the proposed PCPI measures is generally high, with the large
majority of hospitals successfully meeting these metrics more
than 90% of the time. The measurement and reporting of
process measures carry opportunity cost, and implementation
of the proposed process measures may have a limitedTa
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potential to improve patient outcomes. Our findings highlight
the difficulty of identifying novel process measures that
identify practice variations that are associated with patient
outcomes. In the absence of novel PCI-related process
measures, it may be worth focusing quality measurement
efforts on expanding the portfolio of outcomes measures,
such as rates of bleeding, acute kidney injury, and patient-
report health status following PCI.21–23
With an increasing number of performance metrics, NQF
has recommended consideration of composite measures to
provide a more-comprehensive picture of quality.24 Several
composite measures already exist in the NQF’s portfolio of
endorsed measures for other areas of focus, such as acute
myocardial infarction and congestive heart failure.24,25 Given
the increased number of PCI-related process measures, there
may be advantages to creating a composite measure.26
Nevertheless, we found that much of the variation in the
composite measures reflected variations in referral to cardiac
rehabilitation, bringing into question the efficacy of a
composite measure for PCI.
Our results indicate that there is variation in 30-day risk-
standardized readmission and mortality rates across hospitals
that perform PCI and demonstrate the continued opportunity
to improve the outcomes of patients undergoing these
procedures. Although previous analyses have examined the
association between acute myocardial infarction outcome
metrics and process measures and others have identified
specific clinical profiles and risk factors of PCI patients that
predict outcomes, our study is the first to characterize the
relatively weak relationship between PCI-specific process and
PCI outcome measures.10,27,28 Our findings are relevant given
that there are ongoing efforts to increase quality of care
specifically for PCI patients. Furthermore, our analysis of
recent performance on the PCPI PCI process measures
suggests that despite this effort, there is a continued need to
identify impactful process measures and potentially to shift
focus to outcomes measures to include not only mortality and
readmissions, but also other relevant outcomes such as rates
of acute kidney injury and bleeding.21,22 The absence of a
strong association does not necessarily indicate that there is
no role for process measures in assessing the quality of care
provided to PCI patients. Indeed, many of these measures
have both face validity and substantial evidence supporting
their impact on individual patients. Nevertheless, the fact that
most process measures demonstrate little variation and are
not strongly associated with outcomes suggest the need to
identify additional care processes for which there is a
sufficiently large gap in care to warrant their collection.
Evidence-based processes, including the proposed PCPI
measures, may be necessary, but not sufficient to drive
improvements in the outcomes of PCI patients.
Our study highlights the complementary role of process
and outcome measures in assessing hospital quality and
illustrates that high performance alone on process measures
does not guarantee optimal outcomes. In fact, one can argue
that a hospital’s ability to drive improvements in outcomes
can be limited given the heterogeneity and number of factors
influencing outcomes that are outside a hospital’s control. On
the other hand, there is growing evidence suggesting that
there are implementable hospital strategies to improve quality
of care that are associated with lower mortality and readmis-
sions rates.
For example, previous studies have shown that improve-
ments in hospital systems such as organizational culture,
including interdisciplinary rounding during hospitalization and
at discharge, and optimization of patient care transitions were
associated with improved 30-day outcomes.29–31 Similarly,
other qualitative studies have shown that high-performing
hospitals have specific organizational strategies and enabling
structures that distinguish them, including: active communi-
cation and coordination among care givers; senior manage-
ment-level engagement and support; and an organizational
commitment to developing and maintaining a focus on
delivering high-quality care.32,33 These strategies emphasize
that efforts to improve outcomes need to be multifaceted,
Table 4. Percent Variance in Hospital-Level 30-Day Outcome
Measures for PCI Process Measures*
Variable RSRR %
RSMR %
(STEMI)
RSMR %
(NSTEMI)
Aspirin at discharge 1.5 1.8 5.0
Thienopyridines at
discharge
1.7 2.3 2.0
Statin at discharge 1.9 1.3 5.8
Timely primary PCI 0.4 0.5 0.1
Referral to cardiac rehab 1.0 0.6 0.4
Documentation of
contrast dose
0.0 0.0 0.0
Use of embolic device 0.2 0.0 1.8
Documentation of PCIs
with GFR documentation
0.1 1.0 0.0
Documentation of
PCI indications
0.4 0.0 0.1
Proportion of appropriate
elective PCIs performed
0.2 0.1 0.1
Overall proportion of existing
and emerging process
measures met
2.0 0.7 1.3
GFR indicates glomerular filtration rate; NSTEMI, non-ST segment elevation myocardial
infarction; PCI, percutaneous coronary intervention; RSMR, risk-standardized mortality
rate; RSRR, risk-standardized readmission rate; STEMI, ST-elevation myocardial
infarction.
*Hospitals were considered eligible only if they had more than 25 patients for each of
the individual process measures.
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involving a level of complexity that may not be captured by
well-described processes such as discharge medications.
Developing effective ways to promote the uptake of these
strategies and structures at PCI hospitals will be needed to
improve the outcomes of PCI patients and reduce variation in
PCI outcomes across hospitals.
There are several limitations to our study that warrant
consideration. First, our patient population was derived
from a single registry, and our results may not be
generalizable to all PCI centers in the United States.
However, the registry captures over 95% of PCI procedures
performed in the United States, and we believe our data
sample is likely representative of the US experience. In
addition, given the data elements available in the registry,
we were not able to characterize hospital performance on
all of PCPI’s proposed process measures, and it is possible
that the additional measures or a composite measure
reflecting all existing and proposed PCI process measures
would be more strongly associated with 30-day outcome
measures. Furthermore, our outcomes data were restricted
to Medicare beneficiaries and may not be representative of
the US population overall.
In summary, hospital performance on current and emerg-
ing PCI-metrics only explain a small amount of the variation in
30-day risk-standardized mortality and readmission rates. This
fact highlights that these 3 sets of markers are all capturing
distinct aspects of hospital quality. Additional efforts are
needed to better characterize how hospitals can utilize these
distinct markers of quality to improve hospital performance.
The CathPCI Registry is an initiative of the American
College of Cardiology with partnering support from The
Society for Cardiovascular Angiography and Interventions.
Figure 2. Risk-standardized outcomes based on performance on percutaneous coronary intervention (PCI) process metrics. Box-and-whiskers
plot of hospital performance on 30-day risk-standardized readmissions and mortality rates in STEMI/cardiogenic shock (A) and non-STEMI/no
cardiogenic shock (B) patients as stratified by quintiles of hospital performance on overall proportion of PCI process measures met. There is
minimal variation in hospital performance on readmission (C) and mortality rates in relationship to respective quintiles of hospital performance
on overall PCI process measures met. Central band represents median, box hinges represent the first and the third quintiles, and whiskers
extend to 1.5 times the interquartile range. Diamonds represent the means and circles represent outlier hospitals. STEMI indicates ST-elevation
myocardial infarction.
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